Partner with Us

Why to join SMART NT Network?

Every practitioner performing early pregnancy scans has encountered a 10-week fetus with a “hydropic appearance” or marked skin oedema. In such situations, professionals often feel frustrated: the baby looks unwell, yet there is no clear pathway for management. The immediate questions are whether to inform the parents and which tests to arrange, or where to refer. It is clear that the CVS option does not exist at 10 weeks. So, should we “ignore” the finding and rescan in two weeks to measure the NT? Does that sound correct?

We have developed a clear, streamlined 10 weeks NT pathway that combines high-resolution scans with advanced NIPT. Train with us, partner with us, and improve care for pregnant women.

Who can collaborate with us?

We collaborate with sonographers, obstetricians, early pregnancy or fetal medicine specialists and clinics across both the NHS and private sector. We are equally keen to partner internationally for training, accreditation and rollout.

Based in London, UK, we work with providers delivering first-trimester scanning in any setting. We’re actively seeking global collaborations for training, certification and implementation.

How can other providers access our pathway?

For Greater London providers
If you have a patient at 9–10 weeks with increased nuchal translucency (NT), generalised fetal oedema, cystic hygroma, or early fetal hydrops, please refer her to our clinic for assessment and discussion of the SMART NT pathway. She will receive a discounted 10-week scan as soon as possible (usually within 24–48 hours), discounted KNOVA NIPT, and a targeted scan at 12–13 weeks.

For providers elsewhere in the UK
This pathway may be less practical because of the logistics of travelling to London. We will accept a report from an NHS or other CQC-registered ultrasound provider (an image of the increased NT measurement is essential). We will arrange online NIPT counselling promptly and send a KNOVA kit by courier with instructions. We strongly advise arranging and attending our clinic for the 12–13-week targeted scan.

Please note: the pathway for SMART NT Affiliated Clinics is different.

How to refer the patient for second opinion?

Early concerns at 9–10 weeks are not limited to increased NT. It’s not uncommon to see a viable fetus at 9–10 weeks with features that look abnormal or unusual, yet there is often no clear UK referral pathway to a Fetal Medicine Unit at this stage. EPAU services are excellent for maternal and gynaecological emergencies and confirming viability, but they are not designed for detailed early fetal anatomical assessment or genetics counselling.

We provide a solution. We offer discounted second-opinion scans led by fetal-medicine specialists, with same- or next-day appointments where possible. We will update you on your patient’s findings and advise on any further actions if required.

What training & protocols are available?

You can download our "10 Week NT Measurement and Management Protocol (LPC) - 2025" here.

Starting in 2026, we will launch our free introductory course, Increased NT at 10 Weeks: Diagnosis, Management and Prognosis.

We will then introduce our advanced training module, SMART 10–16: Encyclopaedia of Early Anomalies - Scan + NIPT pathway

‍This will be followed by a formal certification and affiliation programme.

Can you get remote review & NIPT access?

Treatment for breast cancer depends on the type, stage, and whether the cancer has spread. Common treatments include surgery to remove the cancer, radiotherapy to destroy any remaining cancer cells, and chemotherapy to target cancer throughout the body. Some women may also be offered hormone therapy or targeted therapy, depending on the cancer's characteristics.

In cases of hereditary breast cancer, treatment plans may also include discussions around preventative options, such as risk-reducing surgery (e.g. double mastectomy), particularly if a high-risk gene is involved. Your care team will work with you to choose the best treatment approach for your situation, focusing on both effectiveness and quality of life.